Bayer stepping up its commitment towards SDG 3.7.1
Commitment description:Bayer’s long-term commitment to family planning will be reinforced in accordance to the ICPD Programme of Action and 2030 SDGs. The company has been supporting family-planning programs with a broad range of hormonal contraception methods for many years. In addition to oral contraceptives, these products include monthly and three-monthly injections as well as a contraceptive implant. Increasing demand in low -and low middle income countries has been seen particularly regarding longacting, reversible contraceptives (LARCs), including implants. Bayer plans to increase production capacity for LARCs, including an intrauterine device. At the same time it will ensure the availability of short acting contraceptives. Through new partnerships Bayer plans to contribute to a multi-stakeholder fund to drive innovative and sustainable Family Planning programs in line with the ICPD Programme of Action and 2030 SDGs.
Modes of engagement:
- Budgetary and financialBayer will increase production capacities for Implants (30% already in 2020), and explore options to make hormonal IUS more affordable in LMIC, both product categories at preferable Price Levels for the public channel
Value: Significant investments , business case will follow 2020
- Programmatic actionAmong other activities, Bayer intends to partner with the Bill and Melinda Gates Foundation and others to support The Challenge Initiative (TCI) in low ressource urban environments
Uphold the right to sexual and reproductive health care in humanitarian and fragile contexts(12) Ensuring that the basic humanitarian needs and rights of affected populations, especially that of girls and women, are addressed as critical components of responses to humanitarian and environmental crises, as well as fragile and post-crisis reconstruction contexts, through the provision of access to comprehensive sexual and reproductive health information, education and services, including access to safe abortion services to the full extent of the law, and post-abortion care, to significantly reduce maternal mortality and morbidity, sexual and gender-based violence and unplanned pregnancies under these conditions.
